A detailed history of Mayport, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mayport, LLC holds 950 shares of LLY stock, worth $970,615. This represents 0.16% of its overall portfolio holdings.

Number of Shares
950
Previous 899 5.67%
Holding current value
$970,615
Previous $700,000 3.43%
% of portfolio
0.16%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 20, 2025

BUY
$625.65 - $812.69 $31,908 - $41,447
51 Added 5.67%
950 $724,000
Q2 2025

Aug 07, 2025

BUY
$713.71 - $898.95 $4,995 - $6,292
7 Added 0.78%
899 $700,000
Q1 2025

Apr 22, 2025

BUY
$725.72 - $929.72 $202,475 - $259,391
279 Added 45.51%
892 $736,000
Q4 2024

Feb 06, 2025

BUY
$727.2 - $932.06 $2,908 - $3,728
4 Added 0.66%
613 $473,000
Q4 2022

Jan 17, 2023

BUY
$321.55 - $374.67 $195,823 - $228,174
609 New
609 $0

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mayport, LLC Portfolio

Follow Mayport, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayport, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayport, LLC with notifications on news.